New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).In its latest enforcement report, the US health regulator said that Cipla USA, Inc, based in Warren, New Jersey, is recalling certain batches of Nilotinib Capsules in two strengths — 150 mg and 200 mg.The recall involves 271 cartons of one batch and 164 cartons of another batch of the …
Trending
- Mirzapur The Movie Review 2026: Explosive Bhaukaal Saga Delivers Nostalgic Thrills
- Romanchakam Movie Review 2026: A Delightful Youthful Romance That Wins Hearts
- Immortal Movie Review 2026: A Bold Bat-Fantasy Horror That Bites Into New Territory
- Yen Ennai Edho Seidhai Movie Review 2026: A Heartfelt Slice-of-Life Triumph Worth Watching
- Jeevan Ya Bheema Con Review 2026: A Wildly Entertaining Mistaken-Identity Caper That Delivers Big Laughs
- Mahaprabhu Jagannath Movie Review 2026: A Divine Animated Triumph Families Will Love
- Gandhari Movie Review 2026: Taapsee Pannu Delivers a Gripping, Unmissable Thriller
- Why Vitamin D Deficiency Is So Common in India (Even With All That Sunshine)